Literature DB >> 30746192

Effectiveness of a 4-week rehabilitation program on endothelial function, blood vessel elasticity in patients with chronic obstructive pulmonary disease.

Botond Szucs1,2, Mate Petrekanits1,2, Janos Varga3.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) may have considerable cardiovascular risk. Physical activity has a paramount role in COPD treatment. Our aim was to evaluate the applicability of arteriograph in COPD and measure the effectiveness of pulmonary rehabilitation on endothelial function.
METHODS: A total of 40 patients with COPD (FEV1: 45.43±20.20%pred, BMI: 27.99±6.98 kg/m2, male: female was 21:19, age: 65.47±7.39 years) participated in a 4-week rehabilitation program. We used a patented, invasively validated Arteriograph. Blood pressure, pulse, augmentation index (AIX), pulse wave velocity (PWV), diastolic area index (DAI) were registered with functional measurements in pulmonary rehabilitation.
RESULTS: Pulmonary rehabilitation was effective in 6 minutes walking distance (6MWD: 335.32±110.43 vs. 398.32±126.21 m), maximal inspiratory pressure (MIP: 57.72±22.69 vs. 63.63±18.01 cmH2O), chest wall expansion (CWE: 2.84±1.26 vs. 4.00±1.76 cm), breath holding time (BHT: 25.77±10.63 to 29.21±11.60 sec) and grip strength (GS: 24.87±11.88 vs. 27.03±11.43 kg) (P<0.05). Improvement in quality of life was monitored by COPD assessment test marker (CAT: 17.00±8.49 vs. 11.89±7.31, P<0.05). Systolic (133.38±22.15 vs. 126.48±20.22 mmHg) and diastolic blood pressure (76.95±14.37 vs. 75.4±12.7 mmHg) showed a reduction tendency. Pulse also decreased (76.95±14.37 vs. 72.53±13.65 bpm). AIX levels showed slight improvement (3.54±35.59% vs. 2.93±30.79%); 23 patients peripheral circulation progressed. The PWV data showed abnormal elasticity with minimal change (11.74±2.13 vs. 11.4±2.73 m/s); although 20 patients showed improvement. DAI detected slightly diminished coronary circulation with moderate improvement (43.32±6.81 vs. 47.1±7.01 m/s).
CONCLUSIONS: Elevated arterial stiffness, high PWV turned the COPD patients to the high/very high-risk cluster. Rehabilitation resulted significant improvement in MIP, CWE, BHT, 6MWD, CAT with mild, but favorable changes in blood pressure, pulse, AIX, PWV. As a consequence of the four weeks rehabilitation period overall quality of life improved and cardiovascular risk showed a reduction tendency in COPD.

Entities:  

Keywords:  Chronic obstructive pulmonary disease (COPD); cardiovascular risk; endothelial function; pulmonary rehabilitation

Year:  2018        PMID: 30746192      PMCID: PMC6344670          DOI: 10.21037/jtd.2018.10.104

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  51 in total

Review 1.  Genesis of the normal and abnormal arterial pulse.

Authors:  C Vlachopoulos; M O'rourke
Journal:  Curr Probl Cardiol       Date:  2000-05       Impact factor: 5.200

2.  Diminished wave reflection in the aorta. A novel physiological action of insulin on large blood vessels.

Authors:  J Westerbacka; I Wilkinson; J Cockcroft; T Utriainen; S Vehkavaara; H Yki-Järvinen
Journal:  Hypertension       Date:  1999-05       Impact factor: 10.190

3.  Augmentation index is associated with cardiovascular risk.

Authors:  Jens Nürnberger; Ayten Keflioglu-Scheiber; Anabelle M Opazo Saez; Rene R Wenzel; Thomas Philipp; Rafael F Schäfers
Journal:  J Hypertens       Date:  2002-12       Impact factor: 4.844

4.  A SIMPLE FIELD TEST FOR THE ASSESSMENT OF PHYSICAL FITNESS. REP 63-6.

Authors:  B BALKE
Journal:  Rep Civ Aeromed Res Inst US       Date:  1963-04

5.  Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus.

Authors:  P J Chowienczyk; R P Kelly; H MacCallum; S C Millasseau; T L Andersson; R G Gosling; J M Ritter; E E Anggård
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

6.  Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients.

Authors:  J Blacher; R Asmar; S Djane; G M London; M E Safar
Journal:  Hypertension       Date:  1999-05       Impact factor: 10.190

7.  Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.

Authors:  Suellen M Curkendall; Cynthia DeLuise; Judith K Jones; Stephan Lanes; Mary Rose Stang; Earl Goehring; Dewei She
Journal:  Ann Epidemiol       Date:  2005-07-21       Impact factor: 3.797

8.  Arterial stiffness, wave reflections, and the risk of coronary artery disease.

Authors:  Thomas Weber; Johann Auer; Michael F O'Rourke; Erich Kvas; Elisabeth Lassnig; Robert Berent; Bernd Eber
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

9.  Pulmonary rehabilitation programmes in the UK: a national representative survey.

Authors:  Abebaw M Yohannes; Martin J Connolly
Journal:  Clin Rehabil       Date:  2004-06       Impact factor: 3.477

10.  Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial.

Authors:  Andrew L Ries; Robert M Kaplan; Roseann Myers; Lela M Prewitt
Journal:  Am J Respir Crit Care Med       Date:  2002-12-27       Impact factor: 21.405

View more
  3 in total

Review 1.  Molecular Characteristics and Treatment of Endothelial Dysfunction in Patients with COPD: A Review Article.

Authors:  Botond Szucs; Csilla Szucs; Mate Petrekanits; Janos T Varga
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

Review 2.  Effects of high intensity interval training on exercise capacity in people with chronic pulmonary conditions: a narrative review.

Authors:  Abbey Sawyer; Vinicius Cavalheri; Kylie Hill
Journal:  BMC Sports Sci Med Rehabil       Date:  2020-03-30

3.  Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation.

Authors:  Pasquale Ambrosino; Antonio Molino; Ilenia Calcaterra; Roberto Formisano; Silvia Stufano; Giorgio Alfredo Spedicato; Andrea Motta; Antimo Papa; Matteo Nicola Dario Di Minno; Mauro Maniscalco
Journal:  Biomedicines       Date:  2021-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.